Overexpression of SOX4 in MSCs inhibits cellular senescence and enhances therapeutic efficacy in systemic lupus erythematosus
Abstract Background Mesenchymal stem cells (MSCs) are widely used in treating autoimmune diseases. However, replicative senescence limits the quantity and quality of MSCs during population doublings in vitro. Transcription factor SOX4 is a crucial regulator of cell fate and stemness. This study aims...
Saved in:
| Main Authors: | Jingjing Qi, Xiangge Zhao, Xiaoyu Gao, Xiaolu Zhu, Junli Wang, Jiaqing Liu, Jing Wei, Xia Li, Bihu Gao |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-07-01
|
| Series: | Stem Cell Research & Therapy |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s13287-025-04525-w |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
GLUCOCORTICOIDS IN THE THERAPY OF SYSTEMIC LUPUS ERYTHEMATOSUS
by: T. M. Reshetnyak, et al.
Published: (2014-07-01) -
THE REGISTRY OF SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS, A EURASIAN COHORT (RENAISSANCE)
by: E. A. Aseeva, et al.
Published: (2016-12-01) -
Systemic lupus erythematosus presenting as Guillain‒Barre syndrome
by: Arundhati Das, et al.
Published: (2022-01-01) -
Netosis in patients with systemic lupus erythematosus
by: V. V. Zhelezko, et al.
Published: (2020-12-01) -
Efficacy and safety of calcineurin inhibitors use in patients with systemic lupus erythematosus
by: N. Yu. Nikishina, et al.
Published: (2025-06-01)